At the 2023 European Society for Medical Oncology conference, Julie Graff, M.D., presented data on the phase 3 KEYNOTE-641 trial, which did not indicate an overall survival improvement with pembrolizumab plus enzalutamide in metastatic castration-resistant prostate cancer. Graff says: “Future studies should focus on patient selection and the identification of positive predictive markers of response, more so than treating all comers, which several studies have shown has not really worked here or they acknowledge it.”

A letter to the editor of the East Oregonian urges legislature consideration to “create a pathway” for Medicare to cover multi-cancer early detection tests following Food and Drug Administration approval.

A story about Multnomah County no longer employing a staff psychiatrist at its jail notes psychiatric nurse practitioners are available at the jail during the week and that an OHSU fellow does rounds weekly at the jail's acute mental health unit.

In a KGW-TV story about state medical boards not stopping physicians accused of significant wrongdoing from practicing medicine, Juliana Hansen, M.D., provides outside expertise on the case of a Portland woman who died after cosmetic surgery provided by a private practitioner. Hansen says the patient’s death could “absolutely” have been prevented because their health issues meant they “would not be considered a good candidate for a cosmetic procedure done electively in an office that’s not accredited without an anesthesia provider monitoring.”

Allison Empey, M.D., will speak about indigenous health equity Nov. 15 as part of lecture series at the Case Western Reserve University School of Medicine.

The Sandy Seventh-day Adventist Church will host the OHSU mobile mammography van at the church on Nov. 9. Event organizer Tami Beaty says: “I am a breast cancer survivor so, for me, (this service) is very personal. My survivability rate and treatment was so much easier with stage one (cancer).”

Lisa Coussens, Ph.D., was among the speaker line-up selected for the inaugural Zena Werb Memorial Lecture in Cancer Biology at the University of California at San Francisco.

Rosalie Sears, Ph.D., contributed to pancreatic cancer research using exosome-isolating technology.

Kelly Vranas, M.D., and Abby Dotson, Ph.D., offer their insights during a panel podcast discussion about Portable Order for Life-Saving Treatment, or POLST.

While discussing California being the first state to ban four additives, Joel Nigg, Ph.D., describes food dyes as a “public health concern” that affects children with and without ADHD.